SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs KardiaAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by DIACOUSTIC MEDICAL DEVICES (PTY)
VS
by AliveCor

AI Verdict

These tools are adjacent in the cardiology AI space, both assisting in cardiac diagnosis. SensiCardiac Mobi focuses on analyzing acoustic heart signals from an electronic stethoscope to differentiate heart murmurs. In contrast, KardiaAI analyzes ambulatory ECG rhythms to detect various cardiac conditions such as AFib, bradycardia, and tachycardia.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI if your primary need is a mobile, point-of-care solution for real-time auscultation analysis. This tool is ideal for physicians who require AI-powered assistance in differentiating between physiological and pathological heart murmurs directly during a patient examination using an electronic stethoscope. It streamlines the initial screening and characterization of heart sounds.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose KardiaAI if…

Choose KardiaAI if you require an AI-powered software library for comprehensive analysis of ambulatory ECG rhythms. This tool is best suited for integrating advanced cardiac rhythm detection capabilities, such as identifying AFib, bradycardia, and tachycardia, into existing ECG devices, mobile applications, or web platforms for continuous or intermittent monitoring. It provides medical-grade accuracy for automated ECG interpretation.

View KardiaAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION KardiaAI
Pricing Contact for pricing Subscription-based for advanced features and services.
Deployment Hosted server environment (Linux OS) with a mobile application interface Mobile app, cloud-based.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

KardiaAI

Tool B, through its associated products like KardiaMobile, is known for its highly intuitive and user-friendly interface, allowing patients to easily record ECGs. Tool A is a mobile application designed for physicians, requiring an electronic stethoscope, which suggests a more specialized and potentially less broadly accessible user experience.

Clinical Value

Tie

Both tools offer significant clinical value as FDA-cleared AI-powered decision support systems in cardiology. Tool A assists in diagnosing heart murmurs by analyzing acoustic signals, while Tool B detects various cardiac arrhythmias from ECGs. Both address critical aspects of cardiac care with medical-grade accuracy.

Pricing & Value

KardiaAI

Tool B provides transparent, publicly available subscription-based pricing for its integrated services, allowing users to clearly understand the cost and value proposition. In contrast, Tool A's pricing is not publicly available and requires direct contact, making it difficult to assess its value upfront.

Enterprise Readiness

KardiaAI

Tool B is designed as an API library, facilitating seamless integration into existing mobile apps, web platforms, and potentially electronic health record systems, which is crucial for enterprise scalability and workflow embedding. While Tool A is HIPAA compliant and has a BAA, its deployment as a hosted server with a mobile app interface might require more bespoke integration efforts for large enterprises.

Innovation

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Tool A demonstrates a more novel application of AI by analyzing acoustic heart signals to differentiate between physiological and pathological heart murmurs, a less common area for AI in cardiology. While Tool B's AI for ECG analysis is highly valuable, the field of AI-powered ECG interpretation is more established.

Support & Docs

KardiaAI

AliveCor, the company behind KardiaAI, has a well-established ecosystem with extensive public support resources, FAQs, and documentation for its products and services. Information regarding comprehensive support and documentation for Tool A is not readily available or detailed publicly.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION KardiaAI
Name SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION KardiaAI
Company DIACOUSTIC MEDICAL DEVICES (PTY) AliveCor
Description SensiCardiac Mobi is an FDA-cleared AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds. KardiaAI by AliveCor is an FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia.
Primary Function Diagnosing heart murmurs by analyzing acoustic heart signals Analyzing ambulatory ECG rhythms, detecting various cardiac conditions
Key Differentiator (Input) Acoustic heart signals from an electronic stethoscope Ambulatory ECG rhythms

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and KardiaAI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

SensiCardiac Mobi is designed to assist in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope, differentiating between physiological and pathological sounds. In contrast, KardiaAI specializes in analyzing ambulatory ECG rhythms to detect various cardiac conditions such as atrial fibrillation, bradycardia, and tachycardia.
SensiCardiac Mobi functions as a mobile application for data capture and display, complementing a physician's auscultation workflow. KardiaAI, offered as an API library, is designed for deeper integration into existing mobile apps, web platforms, and EHR systems like Epic and GE Healthcare's MUSEu2122 NX, allowing for automated pulling of ECG data into patient records.
SensiCardiac Mobi's algorithm distinguishes between normal and pathological heart murmurs, with a related platform reporting accuracy above 95 percent for murmur detection. KardiaAI demonstrates high accuracy for ECG rhythm analysis, with studies showing 96.6% sensitivity and 94% specificity for AFib detection compared to cardiology over-read of 12-lead EKGs.
SensiCardiac Mobi has demonstrated high usability in clinical settings, suggesting a straightforward learning curve for physicians already familiar with auscultation. KardiaAI is generally considered easy to use by patients and physicians, and its integration as an API library means time-to-value for institutions would be influenced by the initial integration effort, but the end-user experience is streamlined.
For SensiCardiac Mobi, multi-site rollout would involve standardizing compatible electronic stethoscopes and mobile devices across locations, with the potential for centralized user management. KardiaAI's API-based integration into EHRs like Epic and GE Healthcare's MUSEu2122 NX facilitates deployment across large health systems by leveraging existing IT infrastructure and workflows.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.